Biomarkers in Prediction of AMI (BIPAMI)

University of Tartu

Status: Enrolling

Conditions: Acute Mesenteric Ischemia

Treatments: Diagnostic Test: Sequential blood samples

Study type: Interventional

Funder types: Other

Identifiers

NCT06212921

BIPAMI study

Details and patient eligibility

About

Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.

Enrollment: 250 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 18 years or older
• Initial decision in favour of further diagnostics of mesenteric ischaemia

Exclusion criteria

• Age <18 years
• Consent declined by patient or next of kin (delayed consent)
• Chronic mesenteric ischaemia without an acute event
• Immediate decision for withdrawal of further diagnostics and active treatment
• Referral from another hospital with already established diagnosis of AMI
• AMI diagnosed at surgery without previously having been considered

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

250 participants in 1 patient group

Patient with suspicion of acute mesenteric ischaemia

Other group

Description:

Bolld samples is the only intervention. All patients with suspicion of AMI will be included and blood samples collected

Treatment:

Diagnostic Test: Sequential blood samples